Abstract:Qinghe Zeng, 1, 2, &ast Qi Sun, 3, &ast Huihui Xu, 1, 2, &ast Jiali Chen, 1 Houfu Ling, 4 Qinwen Ge, 1, 2 Kaiao Zou, 1, 2 Xu Wang, 1, 2 Hongting Jin, 1 Ju Li, 4, &ast Minwei Jin 4, &ast 1 Institute of Orthopedics and Traumatology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 2 The First College of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 3 Department of Orthopaedic Surgery, Fuyang Orthopaedics and Traumatology Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China; 4 Department of Orthopaedics, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Minwei Jin; Ju Li, Email ; Background: Intervertebral disc degeneration (IDD) is a major cause of lower back pain (LBP), in which inflammatory is frequently involved. Amygdalin (AMD) is a naturally occurring compound that exerts anti-fibrotic, anti-inflammatory, analgesic, and immunomodulatory effects in various diseases. The purpose of this study was to investigate the therapeutic effects and molecular mechanisms of AMD on Lumbar spine instability (LSI)-induced IDD in mice. Methods: In this study, we first explored the effects of AMD in vivo, and then further explored the mechanism of its effects both in vivo and in vitro. Ten-week-old male C57BL/6J mice were administrated with AMD. At 10 weeks after LSI, spinal were collected for tissue analyses, including histology, micro-CT, and immunohistochemistry for Col2, Mmp-13, TNF-α, and p-P65. Additionally, we also evaluated the mRNA and protein expression level of p-P65 and p-IKBα after being treated with AMD in vitro. Results: Histological staining, micro-CT and immunohistochemical analysis showed that AMD treatment significantly inhibited the expression of TNF-α and Mmp-13, increased the expression of Col2 as well as attenuated the calcification of cartilage endplates, eventually to delayed the progression of IDD. Meanwhile, in vivo and in vitro fluorescence imaging revealed that AMD markedly inhibited the AMD significantly inhibited the LSI-induced increase in TNF-α expression and P65and IKBα phosphorylation. Discussion: Our findings suggest that AMD partly inhibits the activation of NF-κB signaling pathway to reduce the release of inflammatory mediators and delay the degeneration of cartilage endplate in IDD model mice. Therefore, AMD may be a potential candidate for the treatment of IDD. Keywords: intervertebral disc degeneration, amygdalin, cartilage endplate, inflammatory processes, NF-κB pathway Low back pain (LBP) is one of the common orthopaedic diseases in daily life, and its prevalence is increasing with age, and it is also related to excessive exercise. 1,2 This not only affects people's quality of life but also increases the burden of social medical resources. 3 As research has found, disc degeneration is closely linked to LBP and is one of the main causes of LBP. 4 However, the exact mechanism of Intervertebral disc degeneration (IDD) has not yet been elucidated. 5 The intervertebral disc (IVD) is a fibrocartilaginous disc between two adjacent pyramids, consisting of the nucleus pulposus (NP), the annulus fibrosus (AF), and the upper and lower cartilage endplates (CEP). Modern studies have found that IDD is mainly manifested in the reduction of the number of NP cells, abnormal ECM metabolism, reduction of type II collagen, and calcification and death of endplate chondrocytes, etc. 6 Nowadays, the therapeutic strategies to treat IVD degeneration and assuage IDD-related pain include conservative treatments, such as anti-inflammatory drugs. When these treatments prove themselves inefficient, radical surgical interventions (eg disc removal and spinal fusion) are considered. These changes are closely related to the inflammatory response mediated by cellular inflammatory factors. Inflammation not only reduces the synthesis of extracellular matrix such as proteoglycans and type II collagen but also promotes the expression of matrix metalloproteinases (MMPs), which further reduces the biological properties of cartilage endplates and eventually leads to IDD. 7–9 For example, administration of Chlorogenic Acid (CGA) mitiga -Abstract Truncated-

Panax Notoginseng Saponins Attenuate Intervertebral Disc Degeneration by Reducing the End Plate Porosity in Lumbar Spinal Instability Mice

Differentiation of Pluripotent Stem Cells into Nucleus Pulposus Progenitor Cells for Intervertebral Disc Regeneration

Honokiol Alleviates the Degeneration of Intervertebral Disc Via Suppressing the Activation of TXNIP-NLRP3 Inflammasome Signal Pathway.

Lycorine Suppresses Endplate-Chondrocyte Degeneration and Prevents Intervertebral Disc Degeneration by Inhibiting NF-κB Signalling Pathway

Polydatin suppresses nucleus pulposus cell senescence, promotes matrix homeostasis and attenuates intervertebral disc degeneration in rats

Dehydrocostus Lactone Attenuates The Senescence Of Nucleus Pulposus Cells And Ameliorates Intervertebral Disc Degeneration Via Inhibition Of Sting-Tbk1/Nf-Kappa B And Mapk Signaling

Apigenin Alleviates Intervertebral Disc Degeneration via Restoring Autophagy Flux in Nucleus Pulposus Cells

A structured biomimetic nanoparticle as inflammatory factor sponge and autophagy-regulatory agent against intervertebral disc degeneration and discogenic pain

Rebalance of the Polyamine Metabolism Suppresses Oxidative Stress and Delays Senescence in Nucleus Pulposus Cells

Dehydrocostus Lactone Attenuates the Senescence of Nucleus Pulposus Cells and Ameliorates Intervertebral Disc Degeneration via Inhibition of STING-TBK1/NF-κB and MAPK Signaling

Cordycepin Inhibits LPS-induced Inflammatory and Matrix Degradation in the Intervertebral Disc

POSTN promotes nucleus pulposus cell senescence and extracellular matrix metabolism via activing Wnt/β-catenin and NF-κB signal pathway in intervertebral disc degeneration

An anti-senescence hydrogel with pH-responsive drug release for mitigating intervertebral disc degeneration and low back pain

Dihydroartemisinin Attenuated Intervertebral Disc Degeneration Via Inhibiting PI3K/AKT and NF-κB Signaling Pathways

Activation of the Nrf-2 pathway by pinocembrin safeguards vertebral endplate chondrocytes against apoptosis and degeneration caused by oxidative stress

Self-healing Hydrogels Loaded with Spatholobi Caulis Alleviate Disc Degeneration by Promoting Autophagy in Nucelus Pulposus

Fucoidan-functionalized gelatin methacryloyl microspheres ameliorate intervertebral disc degeneration by restoring redox and matrix homeostasis of nucleus pulposus

Protective effects of ginsenoside Rh1 on intervertebral disc degeneration through inhibition of nuclear factor kappa-B signaling pathway

Ginsenoside Rg3 exhibits anti-catabolic and anti-apoptotic effects in IL-1β treated human disc nucleus pulposus cells and in a rat model of disc degeneration by inactivating the MAPK pathway

Polyphenols as Potential Antioxidants for the Treatment of Intervertebral Disc Degeneration.

Amygdalin Delays Cartilage Endplate Degeneration and Improves Intervertebral Disc Degeneration by Inhibiting NF-κB Signaling Pathway and Inflammatory Response